We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+8.64%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$622B
AUM Growth
+$11.2B
Cap. Flow
-$16.1B
Cap. Flow %
-2.59%
Top 10 Hldgs %
26.59%
Holding
3,066
New
113
Increased
1,569
Reduced
1,081
Closed
107

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$1.6B
2
VZ icon
Verizon
VZ
+$1.3B
3
USB icon
US Bancorp
USB
+$1.26B
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.26B
5
LRCX icon
Lam Research
LRCX
+$1.18B

Sector Composition

Rank Sector Weight
1 Technology 26.7%
2 Healthcare 19.64%
3 Financials 12.71%
4 Consumer Discretionary 10.95%
5 Communication Services 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UP icon
2851
Wheels Up
UP
$187M
$29K ﹤0.01%
141
+16
+13% +$4.13K
FFAI
2852
Faraday Future Intelligent Electric
FFAI
$11.7M
0
DNMR
2853
DELISTED
Danimer Scientific, Inc.
DNMR
$29K ﹤0.01%
407
+51
+14% +$4.82K
LU icon
2854
Lufax Holding
LU
$1.31B
$28K ﹤0.01%
3,550
POWW icon
2855
Outdoor Holding Co
POWW
$259M
$27K ﹤0.01%
15,592
+1,818
+13% +$4.58K
CMRX
2856
DELISTED
Chimerix, Inc.
CMRX
$27K ﹤0.01%
14,279
PRCH icon
2857
Porch Group
PRCH
$1.86B
$26K ﹤0.01%
13,968
+509
+4% +$899
EGIO
2858
DELISTED
Edgio, Inc. Common Stock
EGIO
$26K ﹤0.01%
578
+42
+8% +$3.24K
CRGE
2859
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$26K ﹤0.01%
21,315
+2,140
+11% +$4.17K
RNAC icon
2860
Cartesian Therapeutics
RNAC
$268M
$25K ﹤0.01%
727
POL
2861
DELISTED
Polished.com Inc.
POL
$25K ﹤0.01%
875
+157
+22% +$4.71K
CTV
2862
DELISTED
Innovid Corp.
CTV
$23K ﹤0.01%
13,299
+1,480
+13% +$4.01K
HYZN
2863
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$23K ﹤0.01%
299
MKFG
2864
DELISTED
Markforged Holding Corporation
MKFG
$22K ﹤0.01%
1,876
+55
+3% +$838
QUMU
2865
DELISTED
Qumu Corp.
QUMU
$22K ﹤0.01%
24,600
OTLK icon
2866
Outlook Therapeutics
OTLK
$163M
$21K ﹤0.01%
962
+132
+16% +$2.87K
APLD icon
2867
Applied Digital
APLD
$8.89B
$20K ﹤0.01%
+10,873
New +$21.4K
OUST icon
2868
Ouster
OUST
$3.31B
$20K ﹤0.01%
2,361
SPIR icon
2869
Spire Global
SPIR
$550M
$20K ﹤0.01%
2,645
LPTH icon
2870
Lightpath Technologies
LPTH
$836M
$19K ﹤0.01%
15,300
CTXR icon
2871
Citius Pharmaceuticals
CTXR
$19.7M
$18K ﹤0.01%
896
BINI
2872
DELISTED
Bollinger Innovations
BINI
0
SKIL icon
2873
Skillsoft
SKIL
$76.9M
$18K ﹤0.01%
679
TFFP
2874
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$18K ﹤0.01%
668
-240
-26% -$11.4K
VIEW
2875
DELISTED
View, Inc. Class A Common Stock
VIEW
$18K ﹤0.01%
319

Similar funds

T. Rowe Price Associates's Q4 2022 Portfolio in Review

As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
  • T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
  • T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
  • T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
  • T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
  • T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
  • T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.

Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.